In a rat model of ischemia/reperfusion injury, PCSK9 inhibitor was shown to reduce cardiac arrhythmias, suggesting potential cardioprotective effects beyond lipid-lowering [32]. Here, PCSK9 is linked to cardiac arrhythmia.